Relationship between clinicopathological parameters and EGFR mutation status in non-small cell lung carcinomas and correlation of PD-L1 expression

被引：0
|
作者：
Cagaptay, S. [1 ]
Gurel, D. [1 ]
Agalar, A. Aysal [1 ]
Ulukus, C. [1 ]
Canaslan, K. [1 ]
Karacam, V. [1 ]
Ulugun, I. [1 ]
Tertemiz, K. C. [1 ]
Oztop, I. [1 ]
机构：
[1] Dokuz Eylul Univ, Izmir, Turkiye
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-20-01
引用
收藏
页码：S437 / S437
页数：1
相关论文
共 50 条
  • [1] The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer
    Gurbuz, Mustafa
    Dogan, Izzet
    Akkus, Erman
    Ozakinci, Hilal
    Tolunay, Pinar Kubilay
    Kalaci, Ender
    Baglan, Tolga
    Koksoy, Elif Berna
    Ceyhan, Koray
    Sak, Serpil Dizbay
    Aydiner, Adnan
    Demirkazik, Ahmet
    Utkan, Gungor
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2022, 70 (02): : 132 - 140
  • [2] Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer
    Ozilhan, Seda Er
    Efil, Safa Can
    Canakci, Dogukan
    Agackiran, Yetkin
    Dede, Didem Sener
    Kandemir, Nilufer Onak
    Dogan, Mehmet
    Unal, Tuba Dilay Kokenek
    Kiran, Merve Meryem
    Kayacetin, Serra
    Balta, Hilal
    Dogan, Hayriye Tatli
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (02)
  • [3] EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis
    Yang, Huimin
    Zhu, Jinxiu
    Xiao, Rendong
    Liu, Yuhang
    Yu, Fanglin
    Cai, Lin
    Qiu, Minglian
    He, Fei
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1001 - 1016
  • [4] EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis
    Huimin Yang
    Jinxiu Zhu
    Rendong Xiao
    Yuhang Liu
    Fanglin Yu
    Lin Cai
    Minglian Qiu
    Fei He
    Cancer Immunology, Immunotherapy, 2022, 71 : 1001 - 1016
  • [5] Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer
    Montero, M. Angeles
    Aricak, Ozan
    Kis, Lorand
    Yoshikawa, Akira
    De Petris, Luigi
    Grundberg, Oscar
    Pham, Hoa H. N.
    Roden, Anja C.
    Fukuoka, Junya
    Attanoos, Richard
    Guijarro, Ricardo
    Alarcon, Felix
    Lindstrom, Kati
    Ortiz-Villalon, Cristian
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 51
  • [6] Correlation between PD-L1 high-expression and EGFR variants in non-small cell lung cancer.
    Liu, Yifei
    Quan, Fei
    Chen, Siqi
    Lu, Guanghua
    Yang, Yuan
    Deng, Wanglong
    Ding, Ran
    Bu, Fanfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer
    Wu, Xiaodong
    Huang, Yan
    Zhao, Qingping
    Wang, Lei
    Song, Xiao
    Li, Yi
    Jiang, Lei
    EJNMMI RESEARCH, 2020, 10 (01)
  • [8] PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer
    Xiaodong Wu
    Yan Huang
    Qingping Zhao
    Lei Wang
    Xiao Song
    Yi Li
    Lei Jiang
    EJNMMI Research, 10
  • [9] Molecular diagnostic characteristics in non-small cell lung carcinomas ( NSCLC) and its relationship with the PD-L1 expression
    Sert, A.
    Sadioglu, A.
    Ekinci, O.
    Ogut, B.
    Inan, M. A.
    Akyurek, N.
    VIRCHOWS ARCHIV, 2024, 485 : S326 - S326
  • [10] Clinicopathological and genomic correlates of PD-L1 expression in nonsquamous non-small cell lung cancer
    Lamberti, Giuseppe
    Spurr, Liam
    Li, Yvonne
    Ricciuti, Biagio
    Recondo, Gonzalo
    Umeton, Renato
    Cherniak, Andrew
    Meyerson, Matthew
    Awad, Mark
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345